Figures & data
Table 1. Primers used in RT-PCR.
Figure 1. SEM photographs from Bio-Oss®-coated polycaprolactone nanofibrous scaffolds fabricated using electrospinning at two magnifications (1.00 kx (a), 5.00 kx (b)).
![Figure 1. SEM photographs from Bio-Oss®-coated polycaprolactone nanofibrous scaffolds fabricated using electrospinning at two magnifications (1.00 kx (a), 5.00 kx (b)).](/cms/asset/405487d8-84bd-46ea-a821-1633afcadeb2/ianb_a_1553785_f0001_b.jpg)
Figure 2. Stem cell images at two magnifications ×10 and ×40, BFP-MSCs (a, b), BM-MSCs (c, d) and USSCs (e, f) at passages two while cultured on tissue culture polystyrene (TCPS) under DMEM supplemented with FBS 10%.
![Figure 2. Stem cell images at two magnifications ×10 and ×40, BFP-MSCs (a, b), BM-MSCs (c, d) and USSCs (e, f) at passages two while cultured on tissue culture polystyrene (TCPS) under DMEM supplemented with FBS 10%.](/cms/asset/365d0642-3f17-4c8a-ad64-d9129b1e10e5/ianb_a_1553785_f0002_b.jpg)
Figure 3. SEM photographs from Bio-Oss®-coated Polycaprolactone nanofibrous scaffolds, two weeks after BFP-MSCs (a, b), BM-MSCs (c, d) and USSC (e, f) seeding under osteogenic differentiation medium at two magnifications.
![Figure 3. SEM photographs from Bio-Oss®-coated Polycaprolactone nanofibrous scaffolds, two weeks after BFP-MSCs (a, b), BM-MSCs (c, d) and USSC (e, f) seeding under osteogenic differentiation medium at two magnifications.](/cms/asset/9db85e3a-9ab8-461a-b125-b7d1b3afc85f/ianb_a_1553785_f0003_b.jpg)
Figure 4. Survival rate of BFP-MSCs, BM-MSCs and USSC while cultured on tissue culture polystyrene (TCPS), polycaprolactone nanofibrous scaffold (PCL) and Bio-Oss®-coated PCL nanofibrous scaffold (PCL-Bio) during days 1, 3, 5 and 7 cultured under DMEM supplemented FBS 10% (asterisks: significant difference between the groups at p < .05).
![Figure 4. Survival rate of BFP-MSCs, BM-MSCs and USSC while cultured on tissue culture polystyrene (TCPS), polycaprolactone nanofibrous scaffold (PCL) and Bio-Oss®-coated PCL nanofibrous scaffold (PCL-Bio) during days 1, 3, 5 and 7 cultured under DMEM supplemented FBS 10% (asterisks: significant difference between the groups at p < .05).](/cms/asset/960807cb-6133-4df4-ada1-7ac4a1c71bf1/ianb_a_1553785_f0004_b.jpg)
Figure 5. Alizarin red staining of BFP-MSCs (a), BM-MSCs (b) and USSCs (c) two weeks after cultured on tissue culture polystyrene (TCPS) under osteogenic differentiation medium, magnification ×40. Calcium content of the stem cells while cultured on tissue culture polystyrene (TCPS), Polycaprolactone nanofibrous scaffold (PCL) and Bio-Oss®-coated PCL nanofibrous scaffold (PCL-Bio) under osteogenic differentiation medium on day 7 (d) and day 14 (e) (asterisks: significant difference between the groups at p < .05).
![Figure 5. Alizarin red staining of BFP-MSCs (a), BM-MSCs (b) and USSCs (c) two weeks after cultured on tissue culture polystyrene (TCPS) under osteogenic differentiation medium, magnification ×40. Calcium content of the stem cells while cultured on tissue culture polystyrene (TCPS), Polycaprolactone nanofibrous scaffold (PCL) and Bio-Oss®-coated PCL nanofibrous scaffold (PCL-Bio) under osteogenic differentiation medium on day 7 (d) and day 14 (e) (asterisks: significant difference between the groups at p < .05).](/cms/asset/4902650a-6cca-40c3-88e1-3b5a584fda84/ianb_a_1553785_f0005_c.jpg)
Figure 6. Alkaline phosphatase (ALP) activity of the stem cells while cultured on tissue culture polystyrene (TCPS), polycaprolactone nanofibrous scaffold (PCL) and Bio-Oss®-coated PCL nanofibrous scaffold (PCL-Bio) under osteogenic differentiation medium on day 7 and day 14 (asterisks: significant difference between the groups at p < .05).
![Figure 6. Alkaline phosphatase (ALP) activity of the stem cells while cultured on tissue culture polystyrene (TCPS), polycaprolactone nanofibrous scaffold (PCL) and Bio-Oss®-coated PCL nanofibrous scaffold (PCL-Bio) under osteogenic differentiation medium on day 7 and day 14 (asterisks: significant difference between the groups at p < .05).](/cms/asset/535eea1d-4d32-4367-b792-141fc81aeeb6/ianb_a_1553785_f0006_b.jpg)
Figure 7. Quantitative expression changes of the Runx2, osteocalcin (BGLAP) and osteonectin in BFP-MSCs, BM-MSCs and USSCs while cultured on polycaprolactone nanofibrous scaffold (PCL) and Bio-Oss®-coated PCL nanofibrous scaffold (PCL-Bio) under osteogenic differentiation medium on days 7 and 14 (asterisks: significant difference between the groups at p < .05).
![Figure 7. Quantitative expression changes of the Runx2, osteocalcin (BGLAP) and osteonectin in BFP-MSCs, BM-MSCs and USSCs while cultured on polycaprolactone nanofibrous scaffold (PCL) and Bio-Oss®-coated PCL nanofibrous scaffold (PCL-Bio) under osteogenic differentiation medium on days 7 and 14 (asterisks: significant difference between the groups at p < .05).](/cms/asset/20fad672-eae4-44b9-b8f0-2f8c917b5ad6/ianb_a_1553785_f0007_b.jpg)